Connection
Srikanth Vallurupalli to Anticholesteremic Agents
This is a "connection" page, showing publications Srikanth Vallurupalli has written about Anticholesteremic Agents.
|
|
Connection Strength |
|
|
|
|
|
0.756 |
|
|
|
-
Lopez-Candales A, Vallurupalli S. PCSK9 Inhibition-A Tale of 2 Potential Treatment Opportunities. JAMA Cardiol. 2021 04 01; 6(4):480-481.
Score: 0.756